Back to search results
Michelle E. Melisko
5.0 out of 5 (140)
Michelle E. Melisko

Michelle E. Melisko, MD

Breast Medical Oncology

Breast Care Center
1825 Fourth St., Third Floor,
San Francisco, CA 94158
+1 more location
(415) 353-7070
5.0 out of 5 (140)
Virtual visits available
5.0 out of 5 (140)
Virtual visits available
Breast Care Center
1825 Fourth St., Third Floor,
San Francisco, CA 94158
+1 more location
(415) 353-7070

Dr. Michelle E. Melisko is a cancer specialist with expertise in caring for patients with breast cancer.

Also active in research, Melisko is interested in evaluating new chemotherapy combinations, biological therapies and immunotherapies for breast cancer, with a particular focus on treating cancer that has spread to the brain. To foster more rapid advances in breast cancer treatment, she educates patients on clinical trials and encourages them to participate when appropriate.

Melisko earned her medical degree at the Wake Forest School of Medicine and completed a residency in internal medicine at Stanford Medicine. She completed a fellowship in hematology and oncology at UCSF.

  • Board Certifications

    American Board of Internal Medicine, Hospice and Palliative Medicine, 2012

    American Board of Internal Medicine, Medical Oncology, 2003

  • Fellowships

    UCSF, Oncology, 2003

  • Residencies

    Stanford University School of Medicine, 2000

  • Internship

    Stanford University Medical Center-GME, Internal Medicine, 1998

  • Education

    Wake Forest University School of Medicine, 1997

  • Languages

    English

Conditions I specialize in

Treatments I provide

Where I see patients (2)

    My reviews

    5.0

    Overall Experience
    140 Ratings
    About our process
    Mar 29, 2025
    I have only good things to say about interacting with Dr Melisko and her nurses. She always leaves me confident I'm getting truthful information and the best of care.
    Mar 15, 2025
    I would always recommend Dr. Melisko as an oncologist
    Feb 15, 2025
    Thank you so much for your care!
    Jan 27, 2025
    Dr. Melisko is an excellent oncologist and practitioner - always caring and concerned for me as a patient and works with me to come up with solutions to whatever problems I might have. I truly appreciate having her as my doctor and feel very fortunate.
    Jan 25, 2025
    Care provider is excellent
    Nov 23, 2024
    I would always recommend Dr. Melisko to anyone going through breast cancer. She is so supportive, caring, professional, and knowledgeable
    Oct 05, 2024
    Great experience. My doctor explained things with a lot more nuance to me. I felt like I left with a care plan that worked for me and I felt good about. I would highly recommend her to friends.
    Aug 31, 2024
    Michelle is amazing - the most caring, conscientious and thorough practitioner. I feel so lucky to have her as my oncologist.
    Jul 26, 2024
    Dr Melisko and her team are amazing. They are knowledgeable, demonstrate empathy and strong subject matter expertise, are responsive, and are never in a rush when answering questions. Everyone who has visited with me for my appts are impressed with the superlative level of care, coordination between Dr Melisko and her team and nurses, and the new facilities. Thank you.
    Jul 24, 2024
    I attribute this provider, Dr. Michelle Melisko, as saving my life. I am very grateful she has been part of my healing team at UCSF .
    Jul 20, 2024
    The most caring, knowledgeable and friendly oncologist I know.
    Jul 17, 2024
    Dr. Melisko is the best - So knowledgeable, kind, and empathic. I feel very lucky to have her as my oncologist.
    Jun 29, 2024
    Dr Melisko is phenomenal.
    Jun 10, 2024
    Dr. Melisko is an outstanding oncologist. She is experienced and sensitive to her patients' preferences and concerns. I'm a long-term patient and value her advice immensely.
    Jun 10, 2024
    I will always recommend Michelle Melisko as she is a wonderful provider very caring and so knowledgeable.
    May 30, 2024
    Excellent
    May 22, 2024
    Dr. Melisko has been wonderful to work with.
    May 17, 2024
    Dr.Melisko provided clear, helpful advice as to how to proceed from here.
    May 01, 2024
    I am so impressed with the degree of professionalism she always displays plus her depth of empathy.
    Mar 25, 2024
    Excellent.
    Mar 23, 2024
    Dr Mellisko is an incredible clinician - her clinical expertise is enhanced by the fact that she actively stays abreast of research in her field and beyond. I feel very lucky to be her patient and trust her completely
    Jan 08, 2024
    I love Dr. Melisko- she is an amazing oncologist and human being.
    Nov 12, 2023
    Dr Melisko is wonderful
    Oct 28, 2023
    Dr. Melisko is an excellent oncologist, with wonderful "bedside manner."
    Oct 23, 2023
    She was efficient, informative and empathetic.
    Oct 10, 2023
    Dr. Melisko is an extraordinary clinician. She is attuned, attentive, caring and really listens. It is a true therapeutic partnership.
    Oct 07, 2023
    I am in great hands with dr Melisko and her fellows
    Oct 05, 2023
    Care provider is excellent!
    Aug 19, 2023
    My care provider is astonishing.
    Jun 26, 2023
    Dr. Melisko is a talented, caring oncologist.
    Jun 12, 2023
    Dr. Melisko is the best of the best. Knowledgeable, authentic, caring. She is an excellent listener and has always dedicated one of the most precious assets - her time, focused on the patient.
    May 27, 2023
    Dr. Melisko is very thorough and detailed oriented. She listens carefully to my concerns. Provides excellent care.

    Selected research

    See all research
    Decorative Caduceus

    A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early...

    Assessed by the time from date of randomization to the date of first occurrence of: - Ipsilateral invasive breast tumor recurrence - Local/regional invasive breast cancer recurrence - Distant recurrence - Contralat...

    Recruiting

    Decorative Caduceus

    A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Can...

    IDFS excluding second non-breast primary invasive cancers

    Recruiting

    Contact me

    Share